Full Text View
Tabular View
No Study Results Posted
Related Studies
Study Evaluating AGG-523 in Subjects With Severe Osteoarthritis Requiring Total Knee Replacement
This study has been completed.
Study NCT00454298   Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received on March 29, 2007.   Last Updated on July 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis
More general conditions related to this trial
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
AGG-523 (Aggrecanase Inhibitor)
Sponsors listed in this trial
Wyeth is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services